These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31069271)

  • 1. P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy.
    Schiff L; Boles NC; Fernandes M; Nachmani B; Gentile R; Blenkinsop TA
    Commun Biol; 2019; 2():162. PubMed ID: 31069271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration.
    Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP
    Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.
    Telander DG; Yu AK; Forward KI; Morales SA; Morse LS; Park SS; Gordon LK
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3112-7. PubMed ID: 27294805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of HSPA13 Inhibits TGFβ1-Induced Epithelial-Mesenchymal Transition of RPE by Suppressing the PI3K/Akt Signaling Pathway.
    Gao F; Li M; Zhu L; Li J; Xu J; Jia S; Ou Q; Jin C; Tian H; Wang J; Xu J; Xu W; Xu GT; Lu L
    Invest Ophthalmol Vis Sci; 2024 Sep; 65(11):1. PubMed ID: 39226050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy.
    Song Y; Liao M; Zhao X; Han H; Dong X; Wang X; Du M; Yan H
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):26. PubMed ID: 34554178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance.
    Yao J; Hu LL; Li XM; Shan K; Zhou RM; Ge HM; Yao MD; Jiang Q; Zhao C; Yan B
    Biomed Pharmacother; 2019 Mar; 111():548-554. PubMed ID: 30597308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranes.
    Asato R; Yoshida S; Ogura A; Nakama T; Ishikawa K; Nakao S; Sassa Y; Enaida H; Oshima Y; Ikeo K; Gojobori T; Kono T; Ishibashi T
    PLoS One; 2013; 8(1):e54191. PubMed ID: 23372684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snail involves in the transforming growth factor β1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells.
    Li H; Wang H; Wang F; Gu Q; Xu X
    PLoS One; 2011; 6(8):e23322. PubMed ID: 21853110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenomic and Transcriptomic Changes During Human RPE EMT in a Stem Cell Model of Epiretinal Membrane Pathogenesis and Prevention by Nicotinamide.
    Boles NC; Fernandes M; Swigut T; Srinivasan R; Schiff L; Rada-Iglesias A; Wang Q; Saini JS; Kiehl T; Stern JH; Wysocka J; Blenkinsop TA; Temple S
    Stem Cell Reports; 2020 Apr; 14(4):631-647. PubMed ID: 32243845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy.
    Amarnani D; Machuca-Parra AI; Wong LL; Marko CK; Stefater JA; Stryjewski TP; Eliott D; Arboleda-Velasquez JF; Kim LA
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3940-3949. PubMed ID: 28777835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
    Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
    Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.
    Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F
    FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-independent activation of platelet-derived growth factor receptor β promotes vitreous-induced contraction of retinal pigment epithelial cells.
    Duan Y; Wu W; Cui J; Matsubara JA; Kazlauskas A; Ma G; Li X; Lei H
    BMC Ophthalmol; 2023 Aug; 23(1):344. PubMed ID: 37537538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effects of Fucoidan on Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells and Progression of Proliferative Vitreoretinopathy.
    Zhang Y; Zhao D; Yang S; Yao H; Li M; Zhao C; Zhang J; Xu GT; Li H; Wang F
    Cell Physiol Biochem; 2018; 46(4):1704-1715. PubMed ID: 29698960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
    Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological vitreous causes cell line-derived (but not donor-derived) retinal pigment epithelial cells to display proliferative vitreoretinopathy-like features in culture.
    Sharma M; Tiwari A; Sharma S; Bansal R; Gupta V; Gupta A; Luthra-Guptasarma M
    Clin Exp Ophthalmol; 2014 Nov; 42(8):745-60. PubMed ID: 24612444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDGFRβ plays an essential role in patient vitreous-stimulated contraction of retinal pigment epithelial cells from epiretinal membranes.
    Yang Y; Huang X; Ma G; Cui J; Matsubara JA; Kazlauskas A; Zhao J; Wang J; Lei H
    Exp Eye Res; 2020 Aug; 197():108116. PubMed ID: 32561481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRT8 phosphorylation regulates the epithelial-mesenchymal transition in retinal pigment epithelial cells through autophagy modulation.
    Miao Q; Xu Y; Yin H; Zhang H; Ye J
    J Cell Mol Med; 2020 Mar; 24(5):3217-3228. PubMed ID: 32022439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein 6 (BMP6) antagonises experimental proliferative vitreoretinopathy established by TGF-β2 stimulation in retinal pigment epithelial cells through modulation of the p38 and JNK MAPK pathways.
    Liu X; Liu M; Chen L
    Cell Tissue Res; 2024 Apr; 396(1):103-117. PubMed ID: 38403744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis in proliferative vitreoretinopathy.
    El Ghrably I; Powe DG; Orr G; Fischer D; McIntosh R; Dua HS; Tighe PJ
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1473-9. PubMed ID: 15111604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.